Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5)

Aleksandar Sekulic; Michael R. Migden; Nicole Basset-Seguin; Claus Garbe; Anja Gesierich; Christopher D. Lao; Chris Miller; Laurent Mortier; Dedee F. Murrell; Omid Hamid; Jorge F. Quevedo; Jeannie Hou; Edward McKenna; Natalie Dimier; Sarah Williams; Dirk Schadendorf; Axel Hauschild

doi:10.1186/s12885-019-5568-6

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5)

Aleksandar Sekulic, Michael R. Migden, Nicole Basset-Seguin, Claus Garbe, Anja Gesierich, Christopher D. Lao, Chris Miller, Laurent Mortier, Dedee F. Murrell, Omid Hamid, Jorge F. Quevedo, Jeannie Hou, Edward McKenna, Natalie Dimier, Sarah Williams, Dirk Schadendorf, Axel Hauschild

Dermatology

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

Following publication of the original article [1], it was reported that the legend for Fig. 1 was incomplete.

Original language	English (US)
Article number	366
Journal	BMC cancer
Volume	19
Issue number	1
DOIs	https://doi.org/10.1186/s12885-019-5568-6
State	Published - Apr 18 2019

ASJC Scopus subject areas

Oncology
Genetics
Cancer Research

Access to Document

10.1186/s12885-019-5568-6

Fingerprint

Dive into the research topics of 'Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5)'. Together they form a unique fingerprint.

Cite this

Sekulic, A., Migden, M. R., Basset-Seguin, N., Garbe, C., Gesierich, A., Lao, C. D., Miller, C., Mortier, L., Murrell, D. F., Hamid, O., Quevedo, J. F., Hou, J., McKenna, E., Dimier, N., Williams, S., Schadendorf, D., & Hauschild, A. (2019). Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5). BMC cancer, 19(1), Article 366. https://doi.org/10.1186/s12885-019-5568-6

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5). / Sekulic, Aleksandar; Migden, Michael R.; Basset-Seguin, Nicole et al.
In: BMC cancer, Vol. 19, No. 1, 366, 18.04.2019.

Research output: Contribution to journal › Comment/debate › peer-review

Sekulic, A, Migden, MR, Basset-Seguin, N, Garbe, C, Gesierich, A, Lao, CD, Miller, C, Mortier, L, Murrell, DF, Hamid, O, Quevedo, JF, Hou, J, McKenna, E, Dimier, N, Williams, S, Schadendorf, D & Hauschild, A 2019, 'Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5)', BMC cancer, vol. 19, no. 1, 366. https://doi.org/10.1186/s12885-019-5568-6

@article{84cf66e5b7fc456094b7458e136cf7ee,

title = "Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5)",

abstract = "Following publication of the original article [1], it was reported that the legend for Fig. 1 was incomplete.",

author = "Aleksandar Sekulic and Migden, {Michael R.} and Nicole Basset-Seguin and Claus Garbe and Anja Gesierich and Lao, {Christopher D.} and Chris Miller and Laurent Mortier and Murrell, {Dedee F.} and Omid Hamid and Quevedo, {Jorge F.} and Jeannie Hou and Edward McKenna and Natalie Dimier and Sarah Williams and Dirk Schadendorf and Axel Hauschild",

note = "Publisher Copyright: {\textcopyright} 2019 The Author(s). Reference:.",

year = "2019",

month = apr,

day = "18",

doi = "10.1186/s12885-019-5568-6",

language = "English (US)",

volume = "19",

journal = "BMC cancer",

issn = "1471-2407",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5)

AU - Sekulic, Aleksandar

AU - Migden, Michael R.

AU - Basset-Seguin, Nicole

AU - Garbe, Claus

AU - Gesierich, Anja

AU - Lao, Christopher D.

AU - Miller, Chris

AU - Mortier, Laurent

AU - Murrell, Dedee F.

AU - Hamid, Omid

AU - Quevedo, Jorge F.

AU - Hou, Jeannie

AU - McKenna, Edward

AU - Dimier, Natalie

AU - Williams, Sarah

AU - Schadendorf, Dirk

AU - Hauschild, Axel

PY - 2019/4/18

Y1 - 2019/4/18

N2 - Following publication of the original article [1], it was reported that the legend for Fig. 1 was incomplete.

AB - Following publication of the original article [1], it was reported that the legend for Fig. 1 was incomplete.

UR - http://www.scopus.com/inward/record.url?scp=85064480173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064480173&partnerID=8YFLogxK

U2 - 10.1186/s12885-019-5568-6

DO - 10.1186/s12885-019-5568-6

M3 - Comment/debate

C2 - 30999949

AN - SCOPUS:85064480173

SN - 1471-2407

VL - 19

JO - BMC cancer

JF - BMC cancer

IS - 1

M1 - 366

ER -

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this